Halozyme Therapeutics Inc (NASDAQ:HALO)

During the Trading Day
14.59 +0.44 / +3.11%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
14.48 -0.11 / -0.75%
Volume: 31.5K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-53.2M-19.8M-53.6M-83.5M
Total Other Cash Flow4.9M5.6M8.4M10.8M
Funds From Operations-46.9M-13.1M-44.1M-71.4M
Funds From/For Other Operating Expenses-1.5M21.2M20.2M-22.2M
Net Cash Flow - Operating Activities-45.4M-34.4M-64.3M-49.2M
InvestingNet Cash Flow Investing-646.5K-828.5K-1.4M-47.9M
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale----------
Common Preferred Redeemed----------
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing----------
Other Uses - Financing----------
Net Cash Flow - Financing61.8M4.7M112.8M25.1M
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
Net Change In Cash15.8M-30.4M47.1M-72.0M

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.